Dr. Eva Feldman to address Michigan Israel Business Bridge Nov. 12 in Grand Rapids
Taubman Institute Director Dr. Eva Feldman will address a special event at the Van Andel Institute in Grand Rapids on Monday, Nov. 12. The meeting is a special networking luncheon with the Michigan Israel Business Bridge, a non-profit association that promotes economic growth in Michigan and Israel.
Dr. Feldman, the Russell N. DeJong professor of neurology at the University of Michigan and leader of the first-ever stem cell trial in patients with ALS, will tell the groups about her groundbreaking collaboration with another stem cell pioneer, Benjamin E. Reubinoff, M.D., Ph.D., of Hadassah University Hospital in Jerusalem. Her talk is entitled "U-M and Hadassah: Engineering stem cells to decode a deadly disease."
The luncheon will take place from noon to 1:30 p.m.; registration is required by Nov. 6. The charge for MIBB members is $30 or $35 for non-members. For complete details, click here.
Help Us Make A Difference. Make A Donation That Could Save Lives.
Taubman Science
ALS patient feels great after stem cell transplant
Took part in Phase I of Dr. Eva Feldman's human clinical trial
Ted Harada tells Crain's Detroit Business that nearly nine months after receiving stem cell injections to his spinal cord, improvement persists.
Click here to read the interview
Clinical Trials
The birth of two human clinical trials
The Taubman Institute’s overriding purpose is to discover potential new treatments that can be tested in clinical trials. Watch as two Taubman Scholars explain how they made it happen.
Taubman Science
Institute training video helps physicians overseas
U-M exam method for diabetic nerve damage translated to Mandarin Chinese. The Taubman institute has produced video of an exam protocol that will help doctors in Asia and elsewhere as they grapple with growing diabetes epidemics and the resulting complications.
news & events
The Latest
Taubman Science
Taubman Scholars direct 31 human clinical trials
Science funded by the Taubman Institute has led to 31 current human clinical trials, studying potential therapies for diseases including breast cancer, muscular dystrophy, diabetes and ALS. See the complete list of trials.
People who care
Generous donors fund institute's summer students
Leadership advisory board members fund Tauber Family Student Internship Program
Three future medical scientists will work with Taubman Institute researchers starting in June.
Accomplishments
State leaders laud Taubman Institute accomplishments
Leaders of state and local government visited the Taubman Institute on March 18 to tour Taubman Scholar labs and discuss the potential medical research offers for both improving the health of residents and establishing new jobs and businesses in Michigan.
Donors pitch in to keep brilliant science minds at U-M Video
